News

For adults with obesity treated with once-weekly tirzepatide, cardiometabolic risk factor improvements were positively ...
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
Oral PL7737 monotherapy produced rapid and significant weight loss after just 4 days of treatment Combination of oral PL7737 and tirzepatide resulted in additive ...
Researchers found that pairing tirzepatide with hormone therapy boosts weight loss success in postmenopausal women—up to 17% ...
Hengrui has reported topline data from the 301 study of their dual GLP-1 and GIP agonist HRS9531, administered as a ...
Oral PL7737 monotherapy produced rapid and significant weight loss after just 4 days of treatmentCombination of oral PL7737 ...
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...
Where, How, and Why You Exercise Affects Mental Health: StudyPublished in Medicine and Science in Sports and Exercise, a recent study from the ...
Wegovy, a weight loss drug, is gaining popularity for its effectiveness, but experts emphasize that it's most successful when ...
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...
If you’re struggling with your body image this summer, there is still time to reach your image goals. Robert Andrews Laser & Medical Aesthetics is here to help you out this summer.
Overview of Obesity Treatment MarketThe global Obesity Treatment Market is valued at USD 22.2 Billion in 2024 and is projected to reach a value of USD 194.1 Billion by 2035 at a CAGR (Compound Annual ...